TickerFacts.

Nautilus Biotechnology, Inc. (NAUT): Capital Expenditures

Annual figures by period end, from SEC filings.

$1.28M
Year ended 2025-12-31
$1.63M
Trailing 12 months to 2026-06-30
-18.1%
3-year compound annual growth
+6.8%
5-year compound annual growth
$2.44M2020-12-31: $921.0K2021-12-31: $2.27M2022-12-31: $2.32M2023-12-31: $2.44M2024-12-31: $2.12M2025-12-31: $1.28M$1.28M
2020-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$1.28M-39.8%2026-02-26, From 2025-01-01
2024-12-31$2.12M-13.1%2026-02-26, From 2024-01-01
2023-12-31$2.44M+5.1%2025-02-27, From 2023-01-01
2022-12-31$2.32M+2.4%2024-02-28, From 2022-01-01
2021-12-31$2.27M+146.4%2023-02-23, From 2021-01-01
2020-12-31$921.0Kn/a2022-02-24, From 2020-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Laboratory Analytical Instruments), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Nautilus Biotechnology, Inc. (NAUT)2025-12-31$1.28M-39.8%
908 Devices Inc. (MASS)2025-12-31$955.0K+58.6%
Seer, Inc. (SEER)2025-12-31$1.80M-49.9%
EyePoint, Inc. (EYPT)2025-12-31$3.28M-19.1%
Quanterix Corp (QTRX)2025-12-31$2.61M-22.4%
Harvard Bioscience Inc (HBIO)2025-12-31$1.26M-52.4%
Cytek Biosciences, Inc. (CTKB)2025-12-31$4.08M+15.9%
Rapid Micro Biosystems, Inc. (RPID)2025-12-31$850.0K-37.7%
Pacific Biosciences of California, Inc. (PACB)2025-12-31$2.71M-56.1%

Compare NAUT, MASS, SEER, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗